Group One Trading’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.41M Buy
34,438
+4,671
+16% +$563K ﹤0.01% 1698
2026
Q2
$3.97M Sell
29,767
-6,000
-17% -$679K 0.01% 1607
2026
Q1
$3.98M Buy
35,767
+18,384
+106% +$2.18M 0.01% 1482
2025
Q4
$2.34M Buy
17,383
+15,578
+863% +$1.7M ﹤0.01% 2145
2025
Q3
$153K Buy
+1,805
New +$111K ﹤0.01% 4947

Other funds holding ABVX

Group One Trading's ABVX Position: Q3 2026 in Review

Group One Trading increased its Abivax (ABVX) stake by 16% in Q3 2026, buying an estimated $563K and bringing the position to 34,438 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Group One Trading first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.98M in Q1 2026. 316 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Group One Trading held 34,438 shares of Abivax worth $3.41M as of Q3 2026.
  • Group One Trading bought 4,671 Abivax shares in Q3 2026, an estimated $563K.
  • Abivax made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #1698 holding.
  • Group One Trading first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
  • Group One Trading's Abivax position peaked at $3.98M in Q1 2026.
  • 316 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.